JPS56110671A - Preparation of thienamycin intermediate - Google Patents

Preparation of thienamycin intermediate

Info

Publication number
JPS56110671A
JPS56110671A JP1324880A JP1324880A JPS56110671A JP S56110671 A JPS56110671 A JP S56110671A JP 1324880 A JP1324880 A JP 1324880A JP 1324880 A JP1324880 A JP 1324880A JP S56110671 A JPS56110671 A JP S56110671A
Authority
JP
Japan
Prior art keywords
compound
formula
ring
groups
thienamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1324880A
Other languages
Japanese (ja)
Inventor
Tetsuji Kametani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP1324880A priority Critical patent/JPS56110671A/en
Publication of JPS56110671A publication Critical patent/JPS56110671A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To prepare an intermediate for the selective synthesis of a natural fermentation type thienamycin, in high yield, by converting the OH or OH and NH2 of an easily preparable specific amino ester compound used as starting material to trialkyl silyl groups, subjecting the compound to ring-closing reaction, and eliminating the trialkylsilyl groups.
CONSTITUTION: A compound of formula VI (R1 and R2 are alkyl) is used as a raw material, and reacted with trialkyl halogenosilane to convert the OH or the OH and the NH2 groups to trialkylsilyl groups. The product is subjected to ring-closing by Gringnard reaction to obtain the compound of formula IX. Elimination of the trialkylsilyl groups gives the thienamycin intermediate of formula II. The compound of formula VI can be prepared by (1) reacting the simple compound of formula III with the compound of formula IV to afford a novel isoxazoline of formula V, and (2) reducing the compound with sodium borohydride, etc. in the presence of nickel chloride, etc. The reduction after the silylation affords the ring-closing reaction keeping the original steric configuration in high yield and low isomer production.
COPYRIGHT: (C)1981,JPO&Japio
JP1324880A 1980-02-06 1980-02-06 Preparation of thienamycin intermediate Pending JPS56110671A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1324880A JPS56110671A (en) 1980-02-06 1980-02-06 Preparation of thienamycin intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1324880A JPS56110671A (en) 1980-02-06 1980-02-06 Preparation of thienamycin intermediate

Publications (1)

Publication Number Publication Date
JPS56110671A true JPS56110671A (en) 1981-09-01

Family

ID=11827898

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1324880A Pending JPS56110671A (en) 1980-02-06 1980-02-06 Preparation of thienamycin intermediate

Country Status (1)

Country Link
JP (1) JPS56110671A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007281417A (en) * 2006-04-04 2007-10-25 Lg Phillips Lcd Co Ltd Light-emitting diode driving device and liquid crystal display using the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007281417A (en) * 2006-04-04 2007-10-25 Lg Phillips Lcd Co Ltd Light-emitting diode driving device and liquid crystal display using the same

Similar Documents

Publication Publication Date Title
PH16371A (en) Process for producing ethanol by continuous fermentation of polysaccharide-containing raw materials
AU585329B2 (en) Novel process for the preparation of aminopropylalkoxysilanes
GB1452182A (en) Crown compounds and processes for their preparation
GB1520522A (en) 16-methyleneprostaglandins
MY109037A (en) Regioselective synthesis of 4-chloro-2- thiophenecarboxylic acid.
JPS56110671A (en) Preparation of thienamycin intermediate
ES401263A1 (en) Penicillin synthesis
AU1028588A (en) Novel crystalline cefadroxil and method for producing it
JPS57139028A (en) Method for producing dipentaerythritol or ditrimethylol-alkane in high ratio as by-product
ES8103038A1 (en) Process for the purification of caprolactame
JPS5711981A (en) Theobromine derivative and its preparation
JPS56164129A (en) Preparation of allyl alcohol
ES8605529A1 (en) Process for the preparation of alpha-aminoalkylphosphonic acids and alpha-aminoalkylphosphinic acids.
JPS565458A (en) Preparation of 1-ethyl-2- 2-methoxy-5- sulfamoylbenzamidemethyl pyrrolidine
JPS5762296A (en) Preparation of 17alpha-hydroxyprogesterone derivative
JPS5430144A (en) Preparation of isocamphane
ES447297A1 (en) Process for the preparation of N-acetoacetyl-2,5-dimethoxy-4-chloroanilide
JPS6413069A (en) Optically active mono-beta-lactam ring derivative and production thereof
JPS5711938A (en) Preparation of 1,1-dialkoxy-3-alkynes
CA1273347C (en)
JPS5724362A (en) Preparation of pindolol
SU521278A1 (en) The method of obtaining 1-silyl-7-lithiumcarborane, a functional group at the silicon atom
JPS57206677A (en) Preparation of furan derivative
JPS56164148A (en) Preparation of 7- 3-isopropylamino-2-hydroxypropoxy indene
JPS53113078A (en) Culture of yeast